By KYIV. Nov 29 (Interfax-Ukraine) – PrJSC Chemical Pharmaceutical Plant Chervona Zirka (Kharkiv) in 2022 reduced its net profit by 40% – to UAH 10.56 million.
According to the company’s report in the information disclosure system of the National Securities and Stock Market Commission, net sales income in 2022 decreased by 18.3% – to UAH 255.721 million.
As reported, in 2021, Chervona Zirka chemical pharmaceutical plant maintained its net profit at the level of UAH 17.553 million.
Chervona Zirka chemical pharmaceutical plant was founded in 1923. Its product range includes drugs from 25 pharmacotherapeutic groups. It covers solid (tablets, capsules), soft (ointments, gels, liniments) and liquid (alcohol tinctures and solutions) dosage forms. In addition, the company produces medical cosmetics and dietary supplements.
